Cypherpunk Technologies Inc.
CYPH
Rank in Stocks
#15580
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the... Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
Share Price
$2.36
Last synced: 2026-11-09
Market Cap
$254.32M
Change (1 day)
-18.06%
Change (1 year)
15.12%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cypherpunk Technologies Inc. (CYPH)
Category
Healthcare
EPS for Cypherpunk Technologies Inc. (CYPH)
EPS as of June 2026 TTM: $0.59
According to Cypherpunk Technologies Inc.'s latest financial reports, its current EPS (TTM) is $0.59. At the end of 2025 the company had an EPS of $0.07, an increase over its 2024 EPS of $-1.81.
EPS history for Cypherpunk Technologies Inc. from 2012 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.59 | 742.86% |
| 2025 | $0.07 | -104.03% |
| 2024 | $-1.81 | -54.52% |
| 2023 | $-3.98 | -17.43% |
| 2022 | $-4.82 | 1.90% |
| 2021 | $-4.73 | 1.94% |
| 2020 | $-4.64 | -68.15% |
| 2019 | $-14.57 | -10.94% |
| 2018 | $-16.36 | -49.58% |
| 2017 | $-32.45 | 18.91% |
| 2016 | $-27.29 | 120.61% |
| 2015 | $-12.37 | -42.33% |
| 2014 | $-21.45 | -12.88% |
| 2013 | $-24.62 | 136.28% |
| 2012 | $-10.42 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | 2,554.24% |
US
|
|
| $-7.07 | -1,298.31% |
US
|
|
| $-5.29 | -996.61% |
AU
|
|
| $12.88 | 2,083.07% |
BE
|
|
| $21.56 | 3,554.24% |
NL
|
Questions about Cypherpunk Technologies Inc.'s earnings per share (EPS)
What is Cypherpunk Technologies Inc.'s earnings per share (EPS)?
Cypherpunk Technologies Inc.'s earnings per share (EPS) over the last twelve months is $0.59, as of Jun 2026.
What was Cypherpunk Technologies Inc.'s earnings per share (EPS) in 2025?
In 2025, Cypherpunk Technologies Inc.'s earnings per share (EPS) was $0.07, compared with $-1.81 in 2024.
How has Cypherpunk Technologies Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Cypherpunk Technologies Inc.'s earnings per share (EPS) was highest in 2025 ($0.07) and lowest in 2022 ($-4.82).
How does Cypherpunk Technologies Inc.'s earnings per share (EPS) compare with similar companies?
Cypherpunk Technologies Inc.'s earnings per share (EPS) ($0.59) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.